Contribute Try STAT+ Today

“Dear Professor Kenyon, I am eleven years old, and, ever since I was six, have developed an acute interest in the study of the extension of human life. I think the research you are doing is amazing. I was wondering if I could meet you to ask some questions about a career in biology?”

SAN FRANCISCO — So began an email from Laura Deming of Auckland, New Zealand, to Cynthia Kenyon, a professor at the University of California, San Francisco. Kenyon had revolutionized aging research with her discovery that a single-gene mutation could double the lifespan of a tiny roundworm called C. elegans. Her finding triggered a hunt for therapies to extend the human lifespan that today is one of the hottest areas in medical research.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy